Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Disarming bacteria to defeat resistant infections. First-in-class non-antibiotic small molecules that target bacterial virulence.
News
Veirulence Ltd.
Veirulence Ltd. is a UK-based biopharmaceutical startup pioneering a first-in-class, non-antibiotic therapeutic approach to combat bacterial infections and the growing global challenge of antimicrobial resistance (AMR).
Read more
Report